MOBIDIAG
LIVE

Serial Number

87764322

Owner

Mobidiag Oy

Attorney

Charles F. Reidelbach, Jr., Esq.

Filing Date

Jan 22, 2018

Add to watchlist:

No watchlists yet
View on USPTO

MOBIDIAG Trademark

Serial Number: 87764322 • Registration: 6144542

MOBIDIAG is a trademark filed by Mobidiag Oy on January 22, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Mobidiag Oy (5 trademarks)

Keilaranta 16 A

Entity Type: 99

Trademark Details

Filing Date

January 22, 2018

Registration Date

September 8, 2020

Published for Opposition

June 23, 2020

Goods & Services

Computer hardware and software for scientific, industrial and medical analysis and research purposes, namely, computer hardware and recorded software for use in in-vitro diagnostics and for detecting nucleic acids or other biological markers, in particular for the diagnosis of medical conditions in humans and animals; laboratory robots

Pharmaceutical and veterinary preparations for detecting nucleic acids or other biological markers from animals or their microbes; sanitary preparations for medical purposes; Medical diagnostic reagents and assays that test for the presence of pathogens and infection; medical diagnostic kits comprised of medical diagnostic reagents and assays that test for the presence of pathogens and infection; medical diagnostic reagents and assays that test body fluids for microorganisms; medical diagnostic kits comprised of medical diagnostic reagents and assays that test body fluids for microorganisms; medical diagnostic reagents for the extraction, amplification, and purification of nucleic acids; clinical medical reagents and assays for the extraction amplification, and purification of nucleic acids

Reagents for scientific and research use; Reagents, other than for medical use, for sale in kit form and comprising of reagents for detecting nucleic acids or other biological markers; Reagents for in-vitro use, other than for medical purposes; Diagnostic preparations and reagents for scientific and research use, for in- vitro use, and other than medical use; chemical tests for scientific and research use for detecting nucleic acids or other biological markers; chemical tests, other than for medical use for sale in kit form for detecting nucleic acids or other biological markers; chemical tests for in-vitro use, other than for medical use, for detecting nucleic acids or other biological markers

Surgical, medical, dental and veterinary equipment and instruments for clinical diagnosis purposes, namely, laboratory equipment for use in in-vitro diagnostics or for detecting nucleic acids or other biological markers, in particular for detecting infectious diseases, for medical purposes

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 8, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 13, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 13, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 13, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 13, 2021 REAP
REGISTERED-PRINCIPAL REGISTER
Sep 8, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 23, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 23, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 3, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 15, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
May 15, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 15, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
May 15, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 15, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 8, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 8, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 8, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 8, 2019 GNRN
NON-FINAL ACTION E-MAILED
Nov 8, 2019 GNRT
NON-FINAL ACTION WRITTEN
Nov 8, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 15, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 15, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 15, 2019 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Feb 19, 2019 GPRN
PRIORITY ACTION E-MAILED
Feb 19, 2019 GPRA
PRIORITY ACTION WRITTEN
Feb 19, 2019 CPRA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 19, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 19, 2018 CRFA
ASSIGNED TO LIE
Nov 19, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 6, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 8, 2018 GNRN
NON-FINAL ACTION E-MAILED
May 8, 2018 GNRT
NON-FINAL ACTION WRITTEN
May 8, 2018 CNRT
ASSIGNED TO EXAMINER
May 2, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 1, 2018 NWOS
NEW APPLICATION ENTERED
Jan 25, 2018 NWAP